EMAPII Monoclonal Antibody Ameliorates Influenza A Virus-Induced Lung Injury

Influenza A virus (IAV) remains a major worldwide health threat, especially to high-risk populations, including the young and elderly. There is an unmet clinical need for therapy that will protect the lungs from damage caused by lower respiratory infection. Here, we analyzed the role of EMAPII, a st...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Hongyan, Chelvanambi, Sarvesh, Poirier, Christophe, Saliba, Jacob, March, Keith L., Clauss, Matthias, Bogatcheva, Natalia V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094359/
https://www.ncbi.nlm.nih.gov/pubmed/29910176
http://dx.doi.org/10.1016/j.ymthe.2018.05.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094359/
https://www.ncbi.nlm.nih.gov/pubmed/29910176
http://dx.doi.org/10.1016/j.ymthe.2018.05.017

Ejemplares similares